MEDIKAMENTENABGABESYSTEME UND VERFAHREN
European patent · EP3946427 · In force
Register entry
- Publication number
- EP3946427
- Application number
- EP19782871
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 23, 2019
- Published
- Feb 9, 2022
- Granted
- May 8, 2024
- Protection ends at the latest
- Sep 22, 2039
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61M 15/08 (2006.01)A61K 38/00 (2006.01)B05B 11/00 (2023.01)C07K 14/605 (2006.01)B05B 11/06 (2006.01)G09B 23/28 (2006.01)A61M 15/00 (2006.01)
- Priority
- US 201962826093 P 29.03.2019
- PCT application
- PCT/US2019/052332 23.09.2019
- PCT publication
- WO2020/204991 08.10.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- May 15, 2026
Transferred
- Owner
- Amphastar Pharmaceuticals, Inc., 11570 6th Street, Rancho Cucamonga, CA 91730, USA → CSP Technologies, Inc., 960 West Veterans Boulevard, Auburn, Alabama 36832, USA
Published in Swissreg on 15.05.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Mar 19, 2025
Change
Published in Swissreg on 19.03.2025
- Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
- May 8, 2024
Granted
Published in Swissreg on 08.05.2024
- May 8, 2024
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 08.05.2024
Parties
Inventor
Indianapolis, Indiana 46206-6288, US
Indianapolis, Indiana 46206-6288, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.